Register entry

Alexion Pharmaceuticals, Inc.

Registered sites
3
Drug products
10
Live patents
4
Countries
2
Base
Ireland
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

3
SiteLocationOperationsFEI
Alexion Pharma International Operations LimitedAthloneIrelandAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture3011532960
Alexion Pharma International Operations LimitedDublinIrelandAnalytical testing, Active ingredient (API) manufacture, Labelling, Packaging3012889718
Alexion Pharmaceuticals Inc.Bogart, GAUnited StatesAnalytical testing, Finished drug manufacture3011263308
Exclusivity

Patents

4

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
VOYDEYADANICOPANFeb 2035
VOYDEYADANICOPANAug 2038
Catalogue

Marketed products

10

Showing 10 of 10.

BrandGeneric nameFormCategory
SOLIRISECULIZUMABINJECTION, SOLUTION, CONCENTRATEBLA
STRENSIQASFOTASE ALFASOLUTIONBLA
STRENSIQASFOTASE ALFASOLUTIONBLA
STRENSIQASFOTASE ALFASOLUTIONBLA
STRENSIQASFOTASE ALFASOLUTIONBLA
UltomirisravulizumabSOLUTION, CONCENTRATEBLA
UltomirisravulizumabSOLUTION, CONCENTRATEBLA
UltomirisravulizumabSOLUTION, CONCENTRATEBLA
VoydeyaDanicopanTABLET, FILM COATEDNDA
VoydeyaDanicopanKITNDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.